Clinical studies recruiting near Box Hill

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Box Hill Hospital · Eli Lilly and Company · NCT07218380 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Box Hill Hospital · Eli Lilly and Company · NCT07369011 DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac
Phase 2 · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Eastern Health-Box Hill Hospital · Boehringer Ingelheim · NCT06531824 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Kura Oncology, Inc. · NCT07007312 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Box Hill Hospital · Takeda · NCT06499285 Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
Phase 2 · Eastern Health Box Hill · Leiden University Medical Center · NCT05393791 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Box Hill Hospital · Bristol-Myers Squibb · NCT06561386 A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).
Phase 1/Phase 2 · Eastern Health Box Hill · Eupraxia Pharmaceuticals Inc. · NCT05608681 A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Phase 2 · Eastern Health - Box Hill Hospital · Vertex Pharmaceuticals Incorporated · NCT07501702 Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Speci
Phase 3 · Box Hill Hospital · Corvus Pharmaceuticals, Inc. · NCT06561048 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Box Hill Hospital · Eli Lilly and Company · NCT07223593 ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
Phase 3 · University of Calgary · NCT06320431 Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Phase 4 · Box Hill Hospital · Todd C. Lee MD MPH FIDSA · NCT06637332 Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Phase 3 · Box Hill Hospital · University College, London · NCT04685616 A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With
Phase 3 · Box Hill Hospital · Janssen Research & Development, LLC · NCT07258511 EXtubation Related Complications - the EXTUBE Study (EXTUBE)
Phase N/A · University Health Network, Toronto · NCT06442930 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · Box Hill Hospital · Eli Lilly and Company · NCT07392190 A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 i
Phase 3 · Box Hill Hospital · Incyte Corporation · NCT07284849 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Box Hill Hospital · Hoffmann-La Roche · NCT05878769 International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Phase N/A · Eastern Health (Box Hill Hospital) · Prostate Cancer Clinical Trials Consortium · NCT03151629 MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Phase 3 · Eastern Health - Box Hill Hospital · Intellia Therapeutics · NCT06128629 PRIORITY-CONNECT 2 Trial
NA · Surgical Outcomes Research Centre (SOuRCe) · NCT06976710 Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
Phase 2/Phase 3 · University of Melbourne · NCT05105633 The EXCEL Registry of Patients Requiring ECMO
Phase N/A · Box Hill Hospital · Australian and New Zealand Intensive Care Research Centre · NCT03793257 A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With
Phase 1 · Atridia Pty Ltd. · NCT06830850 The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Phase 3 · Eastern Health-Box Hill Hospital · Boehringer Ingelheim · NCT06872892 Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis
Phase N/A · Box Hill Hospital · Monash University · NCT06339190 A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 2 · Box Hill Hospital · Hoffmann-La Roche · NCT07287150 Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Phase 2 · Box Hill Hospital ( Site 0203) · Merck Sharp & Dohme LLC · NCT04728893

Look up another city

Look up another condition